CTRI/2019/07/020109已完成未知
Construction and validation of dose-response curve using dicentric chromosome assay based on irradiated peripheral blood samples of healthy individuals.
Manipal School of Life Sciences0 个研究点目标入组 5 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Healthy volunteers: nonsmokers,non exposed to ionizing radiations
- •Cancer patients undergoing CT and or radiotherapy
排除标准
- •Healthy volunteers
- •exposed to ionizing radiations
- •Cancer patients
- •Malignant cancer
研究者
相似试验
招募中
不适用
Determination of the best dose for the electrostimulation of the paravertebral muscles in the force in individuals without chronic low back paiow back painM54.5RBR-2sv9gwniversidade Estadual do Oeste do Paraná (UNIOESTE)
进行中（未招募）
不适用
An evaluation of the dose-response relationship of Cizolirtine citrate 300 mg, twice daily, and 400 mg, twice daily, versus placebo in subjects with urge urinary incontinence.A 12-week, randomised, double-blind, placebo-controlled, multicentre study, parallel-group, Phase III clinical study with a 12 months safety follow-up period.rge Urinary IncontinenceEUCTR2004-001119-69-ESaboratorios Dr. Esteve, SA450
进行中（未招募）
1 期
An evaluation of the dose-response relationship of Cizolirtine citrate 300 mg, twice daily, and 400 mg, twice daily, versus placebo in subjects with urge urinary incontinence.A 12-week, randomised, double-blind, placebo-controlled, multicentre study, parallel-group, Phase III clinical study with a 12 months safety follow-up period.rge Urinary IncontinenceEUCTR2004-001119-69-CZaboratorios Dr. Esteve, SA450
进行中（未招募）
1 期
Investigation of dose response relationships when using low dose naltrexone (LDN) for the treatment of fibromyalgiaFibromyalgiaMedDRA version: 20.0Level: LLTClassification code 10016631Term: Fibromyalgia syndromeSystem Organ Class: 100000004859EUCTR2016-002081-31-DKAnæstesiologisk-intensiv afd V, Odense Universitets Hospital38
已完成
不适用
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart FailureJPRN-UMIN000009924Showa University Northern Hospital100